NCT00577876 Assessment of the Functional Significance of Accessory Pudendal Arteries Status COMPLETED Phase NA
NCT00577356 Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer Status TERMINATED Phase PHASE2
NCT00574769 Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00573833 Internal Radiation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase NA
NCT00573586 Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada Status UNKNOWN Phase NA
NCT00570700 Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00567580 Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00565227 Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. Status TERMINATED Phase PHASE1
NCT00564928 A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT00562380 AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1
NCT00561314 High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer Status COMPLETED Phase PHASE2
NCT00561262 High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer Status COMPLETED Phase PHASE2
NCT00559481 Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy Status WITHDRAWN Phase NA
NCT00559429 Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE1